← Browse by Condition
Medical Condition
cns tumor
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for cns tumor sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 2
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
NCT03838042 Phase 1, Phase 2
Recruiting
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
Enrollment
91 pts
Location
Australia, Austria, ...
Sponsor
University Hospital Heidelberg
NCT06036394
Recruiting
Artificial Intelligence in CNS Radiation Oncology
Enrollment
6,000 pts
Location
India
Sponsor
Tata Memorial Centre
NCT04732065 Phase 1
Recruiting
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Enrollment
208 pts
Location
United States, Nethe...
Sponsor
Sabine Mueller, MD, PhD
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology